Our previous reports regarding RGZ and hepatic steatosis demonstrated that RGZ-mediated improvement of hepatic steatosis is by activating the Sirt6-AMPK pathway in rats and in AML12 mouse hepatocytes [30]. Here, SIRT6 is linked to fatty liver disease.